Stelis Biopharma appoints Mark W. Womack as CEO
He will be responsible for the company's overall strategy and provide the necessary direction and dynamic leadership to R&D, manufacturing, business development, and commercial operations
He will be responsible for the company's overall strategy and provide the necessary direction and dynamic leadership to R&D, manufacturing, business development, and commercial operations
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
He will be stationed at the company HQ in Bengaluru, India
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread
Dr.Reddy's will receive U.S. $6 million upfront upon closing followed by U.S. $9 million one year from closing
MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery
The data should be submitted by August 12th 2021
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
Arrow is the marketing partner in US
Subscribe To Our Newsletter & Stay Updated